Article
Further delineation of 17p13.3 microdeletion involving CRK. The effect of growth hormone treatment.
European journal of medical genetics - 1 Jan 2012
Østergaard John R, Graakjær Jesper, Brandt Carsten, Birkebæk Niels H
Abstract excerpt
Recently, a 17p13.3 microdeletion syndrome characterized by significant postnatal growth retardation, mild to moderate mental retardation and facial dysmorphic manifestations has been delineated to a small region within the area of the Miller-Dieker syndrome critical region. We report a boy with a 284 kb deletion within the Miller-Dieker critical region including CRK, but not involving YWHAE and TUSC5. He showed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
